Clinical trial
A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in…
NCT00398619 · Incyte Corporation, Industry · Completed
Key facts
| NCT number | NCT00398619 |
|---|---|
| Title | A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes |
| Official title | A Double-blind, Placebo Controlled Pharmacodynamic Study of the Effect of INCB013739 on Systemic and Adipose Tissue 11βHSD1 Activity in Obese, Insulin Resistant Subjects. |
| Lead sponsor | Incyte Corporation, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Insulin Resistance, Obesity |
| Intervention type | Drug |
| Interventions | INCB13739 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Nov 14, 2006 |
| Last update posted | Jan 23, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: